hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang上一页:做癫痫病需多少钱
- 2022-05-03癫痫病的患病因素有哪些
- 2022-04-28癫痫孕妇使用抗癫痫药物会增加无济于事风险吗?
- 2022-04-25男人癫痫,这些问题你有关注吗?
- 2022-04-13Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系
- 2022-04-12上海率先探索异地就医门诊费直接结算
- 2022-04-11月经性癫痫患者妊娠期癫痫控制更好
- 男人癫痫,这些问题你有关注吗?
- 癫痫患儿死亡者简析
- 卒中后癫痫首选用药有哪些?疑问卒中后癫痫的4大问题
- Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系
- 上海率先探索异地就医门诊费直接结算
- 月经性癫痫患者妊娠期癫痫控制更好
- 抗癫痫药物预防新发癫痫:任重而道远
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 癫痫治疗障碍仍难以克服
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- 三庚酸酯可治疗1型转运体缺陷综合征
- 不注意这些问题,吃多少药都没用!
- 预测癫痫患者再入院风险
- 预防妇女癫痫的关键
- Sage获得罕见病明星药物FDA快速批准承诺
- 心理百科:春节期间小心疾病
- 38癫痫患者年病史上的感谢信 道出了浓浓的医患情况
- 【用药情报站】临床应用应听取各种药种药物禁忌证?
- 癫痫患者如何克服忘记吃药的问题?
- 特发性癫痫大发作药物治疗的首选
- 北京癫痫手术费用
- FDA批准Aptiom用于治疗患者癫痫发作
- 癫痫患者手术评估新型工具
- 癫痫怎样治疗?xgrb
- 新版医保药品2800种 逢进必谈有哪些药?我们来看看!
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- 治疗癫痫 治疗癫痫偏方大全
- 北京哪家癫痫医院排名好,成本低
- 心率多少正常 如何保持正常心率不变
- 2013国际抗癫痫联合会抗癫痫药用指南
- 做癫痫病需多少钱
- 赤小豆薏米粥
- 小孩癫痫病的症状
- 关于癫痫治疗,患者和罹难者最容易犯的错误
- 病患癫痫病药品要怎么病患好啊
- 导致小儿癫痫病患病因素有哪些
- 肖波教授接受丁香园特派员采访实录
- 疗程小儿癫痫病要多钱
- FDA对怀孕期间用于丙戊酸钠类药物发出警告
- 治疗法癫痫病偏方哪些好啊
- 癫痫患者如何克服明白吃药的毛病
- 癫痫病的就有症状是什么样的
- 千万别过分婴儿癫痫病症状
- 引致小儿癫痫病的常见病因有什么